>
Switch to:

Research Frontiers Total Current Liabilities

: $0.29 Mil (As of Mar. 2022)
View and export this data going back to 1986. Start your Free Trial

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Research Frontiers's total current liabilities for the quarter that ended in Mar. 2022 was $0.29


Research Frontiers Total Current Liabilities Historical Data

The historical data trend for Research Frontiers's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Frontiers Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Current Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.46 0.39 0.23 0.30

Research Frontiers Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Total Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.30 0.28 0.30 0.29

Research Frontiers Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Research Frontiers's Total Current Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.115+0.182
+Other Current Liabilities+Current Deferred Liabilities
=0.001+0
=0.30

Research Frontiers's Total Current Liabilities for the quarter that ended in Mar. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.091+0.186
+Other Current Liabilities+Current Deferred Liabilities
=-5.5511151231258E-17+0.011
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Research Frontiers Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Research Frontiers's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Research Frontiers Business Description

Research Frontiers logo
Industry
Technology » Hardware NAICS : 334419 SIC : 3679
Traded in Other Exchanges
N/A
Address
240 Crossways Park Drive, Woodbury, NY, USA, 11797-2033
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.
Executives
Douglas Family Trust 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
James & Jean Douglas Irrevocable Descendants Trust 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
Douglas Kevin 10 percent owner, other: 13(d)(3) group 125 E. SIR FRANCIS DRAKE BLVD. SUITE 400 LARKSPUR CA 94939
Settle William Graham director 6003 COBRIDGE SQUARE RALEIGH NC 27609
Lapointe Michael R officer: VP-Marketing PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: LAPOINTE MICHAEL R a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Harary Joseph M director, officer: President and CEO PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: HARARY JOSEPH M a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Van Voorhees Seth officer: CFO & VP-Business Development 12 HARVEY DRIVE SHORT HILLS NJ 07078
Daigle Darryl director 3213 WYTCHWOOD DRIVE MORGAN CITY LA 70380
Kaganowicz Alexander director 1217 CARLLS STRAIGHT PATH DIX HILLS NY 11746
Grimes Gregory George director 24 FIFTH AVENUE APT. 1530 NEW YORK NY 10011
Slovak Steven Michael officer: Vice President-Technology 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797
Saxe Robert L director, officer: Chairman of the Board PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SAXE ROBERT L a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Keen Victor F director C/O RESEARCH FRONTIERS INC. 240 CROSSWAYS PARK DRIVE WOODBURY NY 11797
Guthrie Marion Philip director THREE LINCOLN CENTRE 5430 LBJ FWY., SUITE 1480 DALLAS TX 75240
Derby Jack director 399 BOYLSTON STREET BOSTON MA 02117

Research Frontiers Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)